The emerging treatment of this peptide represents a exciting breakthrough in the care of type 2 diabetes. Different to existing medications, tirzepatide affects two pathways – GLP-1 and glucose-dependent https://tirzepatide-peptide086030.dgbloggers.com/42506274/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment